APOBEC3B and cancer: Several studies suggest that APOBEC3B‐catalyzed deaminations are responsible for a large proportion of mutations in a range of cancers, and that these also provide a chronic source of DNA damage in breast cancer and ovarian cancers 12, 13, 14.